Skip to main content

Use the controls below to filter resources by category, search for words or phrases, or filter by multiple attributes including category, format, author and more.

Newest Resources


Advocacy pack for subcutaneous DMPA: Tools for advocacy and communications to increase access to a new type of injectable contraception

Subcutaneous DMPA (DMPA-SC) is an innovative and easy-to-use injectable that is transforming contraceptive access, use, and choice for women and adolescent girls. Advocates have an important role to play in making sure their country’s policies and funding support access to a broad method mix, including new options like DMPA-SC.

The Advocacy Pack for Subcutaneous DMPA is designed to accelerate your advocacy efforts. It consists of evidence-based materials, in English and French, for advocates to use both for their own strategy development and for direct advocacy with decision-makers. Materials are customizable and unbranded so that you can tailor them to your country context.

Institutional Author(s): PATH
Publication date: October, 2019

Task Sharing Family Planning Services to Increase Health Workforce Efficiency and Expand Access: A Strategic Planning Guide

The Task Sharing Strategic Planning Guide is intended to lead program managers, planners, and policymakers through a strategic process to determine if and how task sharing family planning (FP) services can be used to help achieve development goals. Task sharing is defined as the systematic redistribution of family planning services, including counseling and provision of contraceptive methods, to expand the range of health workers who can deliver services (WHO, 2017). Task sharing is a safe, effective, and efficient means to improve access to voluntary sexual and reproductive health services and reach national FP goals.

Institutional Author(s): High Impact Practices in Family Planning (FP HIP)
Publication date: September, 2019

WHO Guideline: recommendations on digital interventions for health system strengthening

This guideline presents recommendations based on a critical evaluation of the evidence on emerging digital health interventions that are contributing to health system improvements, based on an assessment of the benefits, harms, acceptability, feasibility, resource use and equity considerations.

Institutional Author(s): World Health Organization (WHO)
Publication date: June, 2019

Guide Web page

Expanding Access to Injectable Contraceptives through Pharmacies Toolkit

This toolkit contains resources designed to help pharmacy associations become effective advocates and begin working to change policies in their countries. The toolkit can be adapted to advocate for any injectable contraceptive. The toolkit includes a Resource for Considering DMPA-SC.

Institutional Author(s): SHOPS Plus, USAID
Publication date: May, 2019

Tool Web page

Community-Based Access to Injectables Toolkit

This comprehensive toolkit is intended for agencies and organizations working to plan, implement, evaluate, promote, and scale up community-based access to injectables programs and to advocate for changes to national policy and service delivery guidelines.

Institutional Author(s): Knowledge for Health (K4Health)
Publication date: December, 2018

Tool Community-Based Access to Injectables Toolkit

Family Planning: A Global Handbook for Providers

WHO’s global family planning handbook provides high-quality, up-to-date guidance for health-care professionals working in low- and middle-income countries.

Institutional Author(s): World Health Organization (WHO)
Publication date: June, 2018

Guide Web page

Pathways of Change: How DMPA-SC Introduction May Impact a National Family Planning Program

This 4-page brief outlines a theoretical framework on what might result from adding DMPA-SC to a national family planning method mix.

Institutional Author(s): Health Policy Plus (HP+)
Publication date: December, 2017

Brief Pathways of Change: How DMPA-SC Introduction May Impact a National Family Planning Program

Checklist for Screening Clients Who Want to Initiate DMPA (or NET-EN)

The DMPA/NET-EN checklist consists of questions designed to identify medical conditions that would prevent safe DMPA/NET-EN use or require further screening and assess whether a client might be pregnant. It also provides guidance and directions based on clients’ responses.

Institutional Author(s): FHI 360
Publication date: June, 2017

Tool Checklist for Screening Clients Who Want to Initiate DMPA (or NET-EN)

Collaboration helps broaden access to Pfizer’s contraceptive, Sayana® Press (medroxyprogesterone acetate)

This press release announces the price reduction of Sayana Press from $1 to $0.85 per dose in qualifying countries.

Institutional Author(s): Pfizer, Inc.
Publication date: May, 2017

Brief Collaboration helps broaden access to Pfizer’s contraceptive, Sayana® Press (medroxyprogesterone acetate)

Applying a Total Market Approach to DMPA-SC 

This 4-page policy brief describes the total market approach (TMA), an evidence-based process to identify market players and understand how they can contribute to improved access to information, products, and services for family planning. In the complex and dynamic family planning markets that exist today, TMA can help DMPA-SC achieve balanced and sustainable growth.

Institutional Author(s): Health Policy Plus (HP+)
Publication date: February, 2017

Brief Web page